Global anti-fungal drugs market is expected
to reach USD28484.69 million by
2026, growing at CAGR of 10.39% over the forecast period. Fungal infections can lead to
diseases including fungal pneumonia, candidiasis, mucormycosis, among others
and these fungal infections require the dosage of anti-fungal drugs to ensure
effective treatment. The increasing prevalence of fungal infections is
considered the primary driver for the market growth in the forecast period. The
rise in awareness levels among patients regarding the adverse effect of fungal
infection on the human body is significantly accelerating the demand for
anti-fungal drugs around the world. An increase in government funds and
investments to promote research and development activities to formulate
anti-fungal drugs is fueling the market growth. An increase in the use of
anti-fungal drugs coupled with the rising number of anti-fungal drugs available
over-the-counter is expected to boost the market demand. With the surge in
popularity of over-the-counter drugs such as ketoconazole, miconazole,
econazole, amorolfine, several patients are preferring over-the-counter drugs.
The rise in onychomycosis cases, which is a fungal infection affecting fingers
and toenails is also considered a major driver responsible for the high demand
for anti-fungal drugs.
The global anti-fungal drugs
market is segmented into drug class, indication, infection type, route of
administration, end-user, distribution channel, regional distribution, and
company. Based on drug class, market is further divided into azoles, echinocandins,
polyenes, allylamines and others. The azoles segment is expected to dominate
the anti-fungal drugs market in the forecast period owing to their use in
treatment of almost all the indications. Based on indication, the market is
segmented into candidiasis, aspergillosis, dermatophytosis, mucormycosis, and
others. The candidiasis segment is expected to dominate the market owing to
high cases globally associated with the fungal species.
Based on regional analysis, North
America is expected to dominate the anti-fungal drugs market for the next five
years owing to the presence of major market players in the region. The high
prevalence of fungal infections in the region is another crucial factor aiding
the market growth. Well-developed healthcare infrastructure and favorable
government healthcare policies are the other significant factors bolstering the
market growth.
The major players
operating in the global anti-fungal drugs market are Astellas Pharma Inc.,
GlaxoSmithKline Plc, Bayer AG, Dr. Reddy's Laboratories Ltd., Gilead Sciences
Inc., Janssen Pharmaceuticals Inc. (Johnson & Johnson), Pfizer Inc., Sanofi S.A., Merck & Co., Inc.,
Glenmark Pharmaceuticals Ltd., Sun Pharmaceuticals Industries Ltd., Teva
Pharmaceutical Industries Ltd., Viatris Inc. (Mylan Laboratories Inc.), Cipla
Ltd., Zydus Cadila Ltd., Lupin Ltd., Torrent Pharmaceuticals Ltd, Abbott
Laboratories Inc., Novartis AG, Galderma SA among others. Major companies are
developing advanced technologies and launching new anti-fungal drugs to stay competitive
in the market. Other competitive strategies include mergers & acquisitions
and new product developments.
Years considered for this report:
Historical Years: 2016-2019
Base Year: 2020
Estimated Year: 2021
Forecast Period: 2022–2026
Objective of the
Study:
- To analyze the historical growth in the market
size of global anti-fungal drugs market from 2016 to 2020.
- To estimate and forecast the market size of global
anti-fungal drugs market from 2021 to 2026 and growth rate until 2026.
- To classify and forecast global anti-fungal
drugs market based on drug class, indication, infection type, route of
administration, end user, distribution channel, regional distribution, and
company.
- To identify dominant region or segment in the global
anti-fungal drugs market.
- To identify drivers and challenges for global anti-fungal
drugs market.
- To examine competitive developments such as
expansions, new product launches, mergers & acquisitions, etc., in global
anti-fungal drugs market.
- To identify and analyze the profile of leading
players operating in global anti-fungal drugs market.
- To identify key sustainable strategies adopted
by market players in global anti-fungal drugs market.
Click here to download the sample
TechSci Research performed both primary as well as
exhaustive secondary research for this study. Initially, TechSci Research
sourced a list of manufacturers across the globe. Subsequently, TechSci
Research conducted primary research surveys with the identified companies.
While interviewing, the respondents were also enquired about their competitors.
Through this technique, TechSci Research could include the manufacturers who
could not be identified due to the limitations of secondary research. TechSci
Research analyzed the manufacturers, distribution channels and presence of all
major players across the globe.
TechSci Research calculated the market size of global anti-fungal drugs market using a bottom-up approach, wherein data for various end-user
segments was recorded and forecast for the future years. TechSci Research
sourced these values from the industry experts and company representatives and
externally validated through analyzing historical data of various segments for
getting an appropriate, overall market size. Various secondary sources such as
company websites, news articles, press releases, company annual reports,
investor presentations and financial reports were also studied by TechSci
Research.
Key Target Audience:
- Anti-fungal drug manufacturing
companies
- Market research and
consulting firms
- Government bodies such as
regulating authorities and policy makers
- Organizations, forums and
alliances related to anti-fungal drugs market
The study is useful in providing answers
to several critical questions that are important for the industry stakeholders
such as manufacturers, suppliers and partners, end users, etc., besides
allowing them in strategizing investments and capitalizing on market
opportunities.
Report Scope:
In this report, global anti-fungal drugs
market has been segmented into following categories, in addition to the
industry trends which have also been detailed below:
·
Global Anti-Fungal Drugs Market, By
Drug Class:
- Azoles
- Echinocandins
- Polyenes
- Allylamines
- Others
- Global Anti-Fungal Drugs Market, By Indication:
- Candidiasis
- Aspergillosis
- Mucormycosis
- Dermatophytosis
- Others
- Global Anti-Fungal Drugs Market, By Infection Type:
- Superficial Fungal Infection
- Systemic Fungal Infection
- Global Anti-Fungal Drugs Market, By Route of
Administration:
- Topical
- Oral
- Parenteral
- Others
- Global Anti-Fungal Drugs Market, By End-User:
- Homecare
- Hospitals
- Clinics
- Others
- Global Anti-Fungal Drugs Market, By Distribution
Channel:
- Retail
Pharmacy
- Hospital
Pharmacy
- Online
Pharmacy
- Global Anti-Fungal Drugs Market, By Region:
- North America
- United States
- Mexico
- Canada
- Europe
- Russia
- Germany
- France
- United Kingdom
- Italy
- Spain
- Poland
- Asia-Pacific
- India
- China
- Indonesia
- Japan
§
South
Korea
§
Malaysia
§ Brazil
§ Colombia
§ Argentina
o Middle East & Africa
- Nigeria
- Turkey
- South Africa
- Saudi Arabia
- UAE
Competitive
Landscape
Company Profiles: Detailed analysis of the major
companies present in global anti-fungal drugs market.
Available
Customizations:
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The
following customization options are available for the report:
Company Information
- Detailed analysis and
profiling of additional market players (up to five).